Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for DiaCarta Multiplex Coronavirus Test

NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for DiaCarta's QuantiVirus SARS-CoV-2 Multiplex Test Kit.

The test is designed to detect the SARS-CoV-2 Orf1ab gene in upper respiratory specimens and sputum, according to Richmond, California-based DiaCarta. Nucleic acid purification is performed using either MGI Tech's MGIEasy Magnetic Beads Virus DBA/RNA Extraction Kit or Thermo Fisher Scientific's PureLink Viral RNA/DNA Mini Kit, and the test runs on Thermo Fisher's Applied Biosystems QuantStudio 5 RT-PCR instrument or Bio-Rad's CXF384 RT-PCR system.

The test may be used by any lab CLIA-certified to perform high-complexity tests.

In April, DiaCarta said it received EUA for its QuantiVirus SARS-CoV-2 Test Kit, which detects the virus' Orf1ab, N, and E genes.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.